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for FDG-PET, and were 81.3%, 55.1%, 72.4%, 84.1%, 41.5% respec-
tively for CT. The sensitivity rate was 98% for CT plus FDG-PET. 
Conclusion: PET is superior to CT in diagnosis of metastasis of 
MSCLC to mediastinal lymph nodes. PET+CT signiﬁcantly increases 
the sensitivity in diagnosi Non-small cell lung cancer; Radioactive trac-
ers; Tomography, emission-computed; Lymph nodes, mediastinal 
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Background: Lung cancer is the leading cause of cancer death 
worldwide and determining involvement of the mediastinum is of vital 
importance to determine the prognosis and treatment plan. There are 
many mediastinal staging modalities, however, transbronchial needle 
aspirations (TBNA) is an optimal invasive procedure that remains un-
derutilized. Several explanations have been suggested for this underuti-
lization including level of training, fear of complications or a percep-
tion of low yield. This study evaluated the efﬁcacy of transbronchial 
needle aspirations (TBNA) in a large academic center. The procedures 
were done by several endoscopists with varying levels of experience 
from novice to advanced. 
Methods: Records were retrospectively reviewed of all patients that 
had mediastinal sampling using TBNA at the Mayo Clinic, Rochester 
from January 2004 to December 2006. Sensitivity, speciﬁcity and diag-
nostic accuracy of TBNA was calculated for those patients with known 
or suspected lung cancer and mediastinal or hilar adenopathy. 
Results: Four hundred twenty-eights patients, with known or sus-
pected lung cancer and mediastinal lymphadenopathy, had TBNA (180 
females, 248 males, ages 32-95). The sensitivity of TBNA was 60.9%, 
speciﬁcity was 100.0%, and diagnostic accuracy was 65.7%. The 
sensitivity and diagnostic accuracy of station 7 was 63.3% and 69.8% 
respectively. The sensitivity and diagnostic accuracy for station 4R, 4L, 
≥10R and ≥10L were as follows: 59.1% and 64.9%, 60.5% and 68.8%, 
58.0% and 61.8%, and 51.9% and 62.9%. No complications were 
identiﬁed. 
Conclusion: TBNA is effective in determining malignant involvement 
of mediastinum even in a teaching institution with both experienced 
and novice endoscopists. Among the invasive staging modalities, 
TBNA should be considered as one of ﬁrst the procedures for sampling 
mediastinal lymph nodes. 
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Introduction: The incidence of malignant pleural mesothelioma 
(MPM) is increasing. Mediastinal nodal metastasis is usually associated 
with poor outcome after therapy the incidence and pattern of lymph 
node metastases are not well understood.
The aim of this study s to evaluate the prevalence and pattern of lymph 
node metastasis in MPM.
Patients and Methods: A total of 53 patients with pathologically 
proven malignant pleural mesothelioma were included in a study be-
tween January 2002 - December 2006.
The ﬁrst 37 (group I) patients underwent combined modality treat-
ment including primary surgery followed by chemo-radiotherapy, in 
this group no mediastinoscopy was done. The second group included 
16 patients with pre-treatment mediastinoscopy. Patients with negative 
mediastinoscopy were included in a tri modality treatment protocol, 
while those with positive mediastinoscopy, were excluded from this 
protocol.
Results: Among the studied patients, there were 33 males and 20 fe-
males. Right side was affected in 34 patients, the remaining 19 patients 
had left sided lesions, the mean age of the patients was 34 years. A total 
of 18 (34%) patients had positive lymph nodes. In group I, 12 patients 
had positive mediastinal lymph nodes of them only 2 had mediastinal 
lymphadenopathy on pre-operative CT. 
In group II, 4 patients had positive mediastinoscopy and 2 more had 
positive mediastinal nodes on ﬁnal pathology out of reach of mediasti-
noscopy.
Post-operatively, lymph nodes size ranged between 0.3X0.3cm- 
2X2.5cm and the number of nodes dissected was between 5-34 with a 
mean of 14 nodes. 
Post pleuropneumonectomy, 6 patients out of 14 had positive hilar 
lymph node metastases in addition to positive mediastinal lymph nodes. 
There was one patient with N1 disease only.
Of the 49 patients that had undergone surgery, only 7 patients had no 
lung invasion by pathologic evaluation, non of them had positive hilar 
nodes. The mechanism of spread of the disease to hilar lymph nodes 
may be through lung invasion ﬁrst and not a direct spread of the disease 
from the pleura. This observation rise the possibility that mediastinal 
lymph nodes are considered the primary station in patients with MPM 
and hilar lymph node metastasis necessitate lung invasion ﬁrst. Ma-
lignant pleural mesothelioma may also have unusual pattern of nodal 
metastases as we had 2 patients with positive para esophageal and an 
other 2 patients with positive diaphragmatic node within the group with 
mediastinal nodal metastases.
Mediastinal nodal metastases carries a dismal prognosis as no single 
patient with positive mediastinal nodes survived 3 years after tri modal-
ity treatment. 
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Conclusion: There is a high incidence of nodal metastases in patients 
with malignant pleural mesothelioma and the pattern of nodal metasta-
ses may be different from that of lung cancer and multicenter study is 
needed to study this subject accurately.
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Background: Malignant Mesothelioma is a highly aggressive primary 
neoplasm of the pleural, peritoneal, and pericardial surfaces. It is a 
challenging disease in all aspects, from presentation and diagnosis to 
staging and treatment. In the past 50 years, the incidence of malig-
nant pleural mesothelioma (MPM) has been increasing especially in 
developing countries, along with industrial development. The associa-
tion between simian virus (SV40) and malignant pleural mesothelioma 
(MPM) suggests an etiological role for SV40. However, exact patho-
genic mechanisms and possible prognostic value are not clear. Trans-
formation of human cells by SV40 is induced by the large tumor anti-
gen (Tag) and the small tumor antigen (tag). The main mechanism(s) 
by which the Tag induces cell transformation and tumorigenesis is via 
the inactivation of key cellular proteins, such as p53 and pRB family 
proteins. 
Methods: Fresh tumor tissues were obtained from 40 MPM Egyptian 
patients presenting at NCI,Cairo. Of them, 22 were from extra-pleural 
pneumonectomy specimens and 18 from thoracoscopic biopsies. All 
cases were diagnosed as MPM and graded using World Health Orga-
nization (WHO) criteria on hematoxylin and eosin-stained sections 
combined with immunohistochemistry and clinical features. All cases 
diagnosed as MPM were positive for mesothelioma markers (calreti-
nine, mesothelioma antigen, keratin 5/6) and negative for epithelial 
membrane antigen and/or cytokeratin and/or CEA. Sarcomatoid cases 
were diagnosed by being positive for mesothelioma antigen and nega-
tive for vimentin. The samples were also investigated for the pres-
ence of SV40 DNA, altered Rb expression and p53 gene status using 
immunohistochemistry and molecular techniques. Patients were staged 
according to the International Mesothelioma Interest Group (IMIG) 
staging system. The relation between SV40, asbestos exposure, Rb, p53 
and their contribution to clinicopathologic characteristics and overall 
survival (OS) were assessed. 
Results: The age ranged from 20 to 69 years (mean= 45± SD), 21 were 
males and 19 were females. SV40 DNA was detected in 20/40 cases 
and asbestos exposure in 31 cases; 18 of them were SV40 positive. 
Altered p53 and Rb expression were detected in 57.5% and 52.5% 
respectively with no p53 mutation. There was a statistically signiﬁcant 
correlation between the presence of SV40 viral sequences and the path-
ological type of the tumor since 13 out of the 20 SV40 positive cases 
(65%) were of the sarcomatoid/mixed variants compared to 7 (35%) of 
the epithelioid variant (p.= 0.03). Similarly, there was a statistically sig-
niﬁcant correlation between the presence of SV40 viral sequences and 
a positive history of asbestos exposure (p. = 0.03). Univariate analysis 
showed a signiﬁcant correlation between OS and stage (p= 0.03), 
performance status (p=0.04), p53 overexpression (p=0.05), asbestos 
exposure (p=0.002) and SV40 (p=0.001). Multivariate analysis showed 
that when SV40 and asbestos exposure were considered together, only 
combined positivity of both is an independent prognostic factor affect-
ing the OS (p = 0.001).
Conclusion: SV40 and asbestos exposure are common in Egyptian 
MPM denoting a possible etiological role and a synergistic effect for 
both agents. Our results prove that combined positivity for SV40 and 
asbestos exposure is an independent prognostic factor in MPM having 
a detrimental effect on OS .
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Background: Malignant Mesothelioma is a highly aggressive primary 
neoplasm of the pleural, peritoneal, and pericardial surfaces. It is a 
challenging disease in all aspects, from presentation and diagnosis to 
staging and treatment. In the past 50 years, the incidence of malig-
nant pleural mesothelioma (MPM) has been increasing especially in 
developing countries, along with industrial development. The associa-
tion between simian virus (SV40) and malignant pleural mesothelioma 
(MPM) suggests an etiological role for SV40. However, exact patho-
genic mechanisms and possible prognostic value are not clear. Trans-
formation of human cells by SV40 is induced by the large tumor anti-
gen (Tag) and the small tumor antigen (tag). The main mechanism(s) 
by which the Tag induces cell transformation and tumorigenesis is via 
the inactivation of key cellular proteins, such as p53 and pRB family 
proteins. 
Methods: Fresh tumor tissues were obtained from 40 MPM Egyptian 
patients presenting at NCI,Cairo. Of them, 22 were from extra-pleural 
pneumonectomy specimens and 18 from thoracoscopic biopsies. All 
cases were diagnosed as MPM and graded using World Health Orga-
nization (WHO) criteria on hematoxylin and eosin-stained sections 
combined with immunohistochemistry and clinical features. All cases 
diagnosed as MPM were positive for mesothelioma markers (calreti-
nine, mesothelioma antigen, keratin 5/6) and negative for epithelial 
membrane antigen and/or cytokeratin and/or CEA. Sarcomatoid cases 
were diagnosed by being positive for mesothelioma antigen and nega-
tive for vimentin. The samples were also investigated for the pres-
ence of SV40 DNA, altered Rb expression and p53 gene status using 
immunohistochemistry and molecular techniques. Patients were staged 
according to the International Mesothelioma Interest Group (IMIG) 
staging system. The relation between SV40, asbestos exposure, Rb, p53 
and their contribution to clinicopathologic characteristics and overall 
survival (OS) were assessed. 
Results: The age ranged from 20 to 69 years (mean= 45± SD), 21 were 
males and 19 were females. SV40 DNA was detected in 20/40 cases 
and asbestos exposure in 31 cases; 18 of them were SV40 positive. 
Altered p53 and Rb expression were detected in 57.5% and 52.5% 
respectively with no p53 mutation. There was a statistically signiﬁcant 
